March 10, 2025 - 17:00

Providers of reproductive and gender-affirming health care are set to return to the Legislature on Monday, advocating for increased state funding to address a critical need in their services. Despite the growing demand for these essential health services, state allocations have remained stagnant for nearly a decade. This renewed push is not merely a routine request; it comes at a time when federal funding threats have intensified, making the need for state support even more pressing.
The proposed legislation, LD 143, aims to secure additional resources to ensure that reproductive health providers can continue to deliver vital services to their communities. Advocates argue that without sufficient funding, access to necessary health care could be severely compromised, particularly for vulnerable populations who rely on these services. As discussions unfold in the Legislature, the outcome could have significant implications for the future of reproductive health care in the state.
April 19, 2026 - 00:02
IMG Academy, Neuro Challenge Foundation host Parkinson’s wellness event focused on movement and brain healthA unique event at IMG Academy is helping people with Parkinson’s disease stay active while raising awareness about the importance of movement and community support. The recent wellness gathering...
April 18, 2026 - 04:30
\'It\'s personal to me\': Bill requiring mental health awareness training for coaches passes in state HouseA bill requiring mental health awareness training for school athletics staff is headed to the Pennsylvania Senate after passing in the state House on Wednesday. The proposed legislation, which...
April 17, 2026 - 03:07
New Leadership Nominated for the Centers for Disease Control and PreventionIn a move to stabilize a key public health agency, Erica Schwartz has been nominated to serve as the next director of the Centers for Disease Control and Prevention. The nomination comes at a...
April 16, 2026 - 02:18
RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicalsThe U.S. Food and Drug Administration is moving to re-evaluate its stance on a group of unapproved chemicals known as peptides, following a surge in public interest and promotion by high-profile...